One-year results of intravitreal ranibizumab combined with reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy

Madoka Sakurai,Takayuki Baba,Masayasu Kitahashi,Hirotaka Yokouchi,Mariko Kubota-Taniai,Guzel Bikbova,Toshiyuki Oshitari,Shuichi Yamamoto

One-year results of intravitreal ranibizumab combined with reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy

2014

Madoka Sakurai
Takayuki Baba
Masayasu Kitahashi
Hirotaka Yokouchi
Mariko Kubota-Taniai
Guzel Bikbova
Toshiyuki Oshitari
Shuichi Yamamoto

Purpose To compare the 1-year results of intravitreal ranibizumab combined with reduced-fluence photodynamic therapy (RF-PDT) to intravitreal ranibizumab (IVR) alone for eyes with polypoidal choroidal vasculopathy (PCV).

Keywords:

Ranibizumab
Surgery
Medicine
Photodynamic therapy
intravitreal ranibizumab
Ophthalmology
Visual acuity
Foveal thickness

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations